vs
伊顿公司（ETN）与通用电气医疗（GEHC）财务数据对比。点击上方公司名可切换其他公司
伊顿公司的季度营收约是通用电气医疗的1.2倍（$7.1B vs $5.7B），伊顿公司净利率更高（16.0% vs 10.3%，领先5.7%），伊顿公司同比增速更快（13.1% vs 7.1%），过去两年通用电气医疗的营收复合增速更高（10.7% vs 9.0%）
伊顿公司是一家总部位于爱尔兰的跨国电力管理企业，核心行政中心设在美国俄亥俄州比奇伍德，全球员工规模超过8.5万名，旗下产品销往全球175个以上国家和地区的客户市场。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
ETN vs GEHC — 直观对比
营收规模更大
ETN
是对方的1.2倍
$5.7B
营收增速更快
ETN
高出6.0%
7.1%
净利率更高
ETN
高出5.7%
10.3%
两年增速更快
GEHC
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.1B | $5.7B |
| 净利润 | $1.1B | $588.0M |
| 毛利率 | 36.8% | 39.7% |
| 营业利润率 | 18.3% | 14.5% |
| 净利率 | 16.0% | 10.3% |
| 营收同比 | 13.1% | 7.1% |
| 净利润同比 | 16.5% | -18.4% |
| 每股收益（稀释后） | $2.90 | $1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ETNGEHC
| Q4 25 | $7.1B | $5.7B | ||
| Q3 25 | $7.0B | $5.1B | ||
| Q2 25 | $7.0B | $5.0B | ||
| Q1 25 | $6.4B | $4.8B | ||
| Q4 24 | $6.2B | $5.3B | ||
| Q3 24 | $6.3B | $4.9B | ||
| Q2 24 | $6.3B | $4.8B | ||
| Q1 24 | $5.9B | $4.7B |
净利润ETNGEHC
| Q4 25 | $1.1B | $588.0M | ||
| Q3 25 | $1.0B | $446.0M | ||
| Q2 25 | $982.0M | $486.0M | ||
| Q1 25 | $964.0M | $564.0M | ||
| Q4 24 | $971.0M | $721.0M | ||
| Q3 24 | $1.0B | $470.0M | ||
| Q2 24 | $993.0M | $428.0M | ||
| Q1 24 | $821.0M | $374.0M |
毛利率ETNGEHC
| Q4 25 | 36.8% | 39.7% | ||
| Q3 25 | 38.3% | 38.7% | ||
| Q2 25 | 37.0% | 39.6% | ||
| Q1 25 | 38.4% | 42.1% | ||
| Q4 24 | 38.9% | 42.8% | ||
| Q3 24 | 38.6% | 41.7% | ||
| Q2 24 | 38.0% | 41.4% | ||
| Q1 24 | 37.3% | 40.9% |
营业利润率ETNGEHC
| Q4 25 | 18.3% | 14.5% | ||
| Q3 25 | 18.2% | 12.7% | ||
| Q2 25 | 16.9% | 13.1% | ||
| Q1 25 | 18.5% | 13.2% | ||
| Q4 24 | 18.7% | 15.1% | ||
| Q3 24 | 19.0% | 13.9% | ||
| Q2 24 | 18.8% | 12.6% | ||
| Q1 24 | 16.8% | 11.6% |
净利率ETNGEHC
| Q4 25 | 16.0% | 10.3% | ||
| Q3 25 | 14.5% | 8.7% | ||
| Q2 25 | 14.0% | 9.7% | ||
| Q1 25 | 15.1% | 11.8% | ||
| Q4 24 | 15.6% | 13.6% | ||
| Q3 24 | 15.9% | 9.7% | ||
| Q2 24 | 15.6% | 8.8% | ||
| Q1 24 | 13.8% | 8.0% |
每股收益（稀释后）ETNGEHC
| Q4 25 | $2.90 | $1.28 | ||
| Q3 25 | $2.59 | $0.98 | ||
| Q2 25 | $2.51 | $1.06 | ||
| Q1 25 | $2.45 | $1.23 | ||
| Q4 24 | $2.45 | $1.58 | ||
| Q3 24 | $2.53 | $1.02 | ||
| Q2 24 | $2.48 | $0.93 | ||
| Q1 24 | $2.04 | $0.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $803.0M | $4.5B |
| 总债务越低越好 | $8.8B | $10.0B |
| 股东权益账面价值 | $19.4B | $10.4B |
| 总资产 | $41.3B | $36.9B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资ETNGEHC
| Q4 25 | $803.0M | $4.5B | ||
| Q3 25 | $565.0M | $4.0B | ||
| Q2 25 | $584.0M | $3.7B | ||
| Q1 25 | $1.9B | $2.5B | ||
| Q4 24 | $2.1B | $2.9B | ||
| Q3 24 | $2.0B | $3.5B | ||
| Q2 24 | $2.8B | $2.0B | ||
| Q1 24 | $2.4B | $2.6B |
总债务ETNGEHC
| Q4 25 | $8.8B | $10.0B | ||
| Q3 25 | $8.8B | $10.3B | ||
| Q2 25 | $8.8B | $10.3B | ||
| Q1 25 | $7.6B | $8.8B | ||
| Q4 24 | $8.5B | $9.0B | ||
| Q3 24 | $8.7B | $10.3B | ||
| Q2 24 | $8.6B | $9.2B | ||
| Q1 24 | $8.2B | $9.3B |
股东权益ETNGEHC
| Q4 25 | $19.4B | $10.4B | ||
| Q3 25 | $18.8B | $10.0B | ||
| Q2 25 | $18.6B | $9.7B | ||
| Q1 25 | $18.5B | $9.2B | ||
| Q4 24 | $18.5B | $8.4B | ||
| Q3 24 | $19.1B | $8.3B | ||
| Q2 24 | $19.2B | $7.8B | ||
| Q1 24 | $19.3B | $7.4B |
总资产ETNGEHC
| Q4 25 | $41.3B | $36.9B | ||
| Q3 25 | $40.6B | $36.1B | ||
| Q2 25 | $40.5B | $35.5B | ||
| Q1 25 | $39.2B | $33.6B | ||
| Q4 24 | $38.4B | $33.1B | ||
| Q3 24 | $39.2B | $33.9B | ||
| Q2 24 | $39.4B | $31.9B | ||
| Q1 24 | $38.5B | $32.2B |
负债/权益比ETNGEHC
| Q4 25 | 0.45× | 0.96× | ||
| Q3 25 | 0.46× | 1.03× | ||
| Q2 25 | 0.47× | 1.06× | ||
| Q1 25 | 0.41× | 0.95× | ||
| Q4 24 | 0.46× | 1.06× | ||
| Q3 24 | 0.45× | 1.24× | ||
| Q2 24 | 0.45× | 1.18× | ||
| Q1 24 | 0.42× | 1.25× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0B | — |
| 自由现金流经营现金流 - 资本支出 | $1.6B | — |
| 自由现金流率自由现金流/营收 | 22.3% | — |
| 资本支出强度资本支出/营收 | 5.6% | 2.4% |
| 现金转化率经营现金流/净利润 | 1.74× | — |
| 过去12个月自由现金流最近4个季度 | $3.6B | — |
8季度趋势，按日历期对齐
经营现金流ETNGEHC
| Q4 25 | $2.0B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $918.0M | $94.0M | ||
| Q1 25 | $238.0M | $250.0M | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $946.0M | $-119.0M | ||
| Q1 24 | $475.0M | $419.0M |
自由现金流ETNGEHC
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $716.0M | $8.0M | ||
| Q1 25 | $91.0M | $98.0M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $759.0M | $-183.0M | ||
| Q1 24 | $292.0M | $274.0M |
自由现金流率ETNGEHC
| Q4 25 | 22.3% | — | ||
| Q3 25 | 16.8% | — | ||
| Q2 25 | 10.2% | 0.2% | ||
| Q1 25 | 1.4% | 2.1% | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 17.7% | — | ||
| Q2 24 | 12.0% | -3.8% | ||
| Q1 24 | 4.9% | 5.9% |
资本支出强度ETNGEHC
| Q4 25 | 5.6% | 2.4% | ||
| Q3 25 | 2.5% | 2.1% | ||
| Q2 25 | 2.9% | 1.7% | ||
| Q1 25 | 2.3% | 3.2% | ||
| Q4 24 | 4.1% | 1.9% | ||
| Q3 24 | 2.9% | 1.9% | ||
| Q2 24 | 2.9% | 1.3% | ||
| Q1 24 | 3.1% | 3.1% |
现金转化率ETNGEHC
| Q4 25 | 1.74× | — | ||
| Q3 25 | 1.34× | — | ||
| Q2 25 | 0.93× | 0.19× | ||
| Q1 25 | 0.25× | 0.44× | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 1.30× | — | ||
| Q2 24 | 0.95× | -0.28× | ||
| Q1 24 | 0.58× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ETN
| Other | $1.8B | 26% |
| Electrical Global Segment | $1.7B | 24% |
| Aerospace Segment | $1.1B | 16% |
| Vehicle Segment | $586.0M | 8% |
| Original Equipment Manufacturers | $438.0M | 6% |
| Aftermarket Distribution And End User | $403.0M | 6% |
| Commercial | $341.0M | 5% |
| Industrialand Other | $269.0M | 4% |
| Passenger And Light Duty | $244.0M | 3% |
| E Mobility Segment | $124.0M | 2% |
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
